Page 19 | Certara

Blog

Mechanistic Modeling to Meet Challenges in ADC Development

April 4, 2025 Navigating the challenges in antibody-drug conjugates (ADCs) development requires overcoming complex hurdles…

CertaraApril 4, 2025

On-Demand Webinar

Unlocking the Power of Oligonucleotide Therapeutics: A Model-Informed Approach with Certara & Ionis

Clinical Pharmacology Leader, Ionis Pharmaceuticals Pratap Singh, Ph.D., is currently an Executive Director and Franchise…

CertaraApril 3, 2025

On-Demand Webinar

Model-Based Meta-Analysis for All Phases of Drug Development: Capturing the Full Potential of Published Clinical Trial Outcomes [APAC Webinar]

Vice President, Quantitative Science Services, Certara Matt advances the integration of published clinical outcomes data…

CertaraApril 3, 2025

Case Study

Unlocking Success with Phoenix Hosted: Real-World Customer Stories

As part of our Phoenix Hosted webinar, we highlighted three customer success stories showcasing the…

CertaraApril 2, 2025

Blog Knowledge Base

Calculating AUC (Linear and Log-linear)

AUC calculations are simple but nuanced. In this blog, we look at how to calculate…

CertaraApril 2, 2025

Blog Knowledge Base

Accumulation: What It Means and How to Calculate It

Watch our on demand webinar to discover fast, flexible, frictionless PK/PD workflows with Phoenix Cloud.…

CertaraApril 2, 2025

Press Release

Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities

RADNOR, PA — April 1st, 2025 – Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraApril 1, 2025

Blog

How to Make 3rd Party Reconciliation in Clinical Data Management More Efficient

Learn how to streamline 3rd party reconciliation in clinical data management with reusable standards, centralized…

CertaraMarch 31, 2025

On-Demand Webinar

MIDD’s Growing Role in Global Health: A Case Study of Primaquine Exposures in Lactating Women and Breastfed Infants

Explore how model-informed drug development (MIDD) enhanced clinical lactation studies and supported global health policy…

CertaraMarch 28, 2025

Blog

Building effective health economic models: key components for success

March 28, 2025 Editor’s note: This is the first in a series of four articles…

CertaraMarch 28, 2025

Mechanistic Modeling to Meet Challenges in ADC Development

Unlocking the Power of Oligonucleotide Therapeutics: A Model-Informed Approach with Certara & Ionis

Model-Based Meta-Analysis for All Phases of Drug Development: Capturing the Full Potential of Published Clinical Trial Outcomes [APAC Webinar]

Unlocking Success with Phoenix Hosted: Real-World Customer Stories

Calculating AUC (Linear and Log-linear)

Accumulation: What It Means and How to Calculate It

Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities

How to Make 3rd Party Reconciliation in Clinical Data Management More Efficient

MIDD’s Growing Role in Global Health: A Case Study of Primaquine Exposures in Lactating Women and Breastfed Infants

Building effective health economic models: key components for success

Newsletter sign up

Quick links

Solutions

Contact